Biogen, Eisai Report BAN2401 Seemingly Positive In Alzheimer's; Others Skeptical

 
• By Mandy Jackson

Further new data for the Biogen and Eisai drug BAN2401 appear to show it significantly reduces amyloid plaque and cognitive declines in Alzheimer's patients in a dose-dependent manner, but a lot of questions – and skepticism about the data – remain.

The question mark in a number of
QUESTIONS REMAIN OVER NEW BAN2401 DATA • Source: Shutterstock

More from Neurological

More from Therapy Areas